Investors deemed vulnerable if Sigma/CWH deal fails

Analyst warns Sigma share price could take a hit if Chemist Warehouse merger is blocked Sigma Healthcare investors could be exposed to downside risk if the competition watchdog doesn’t approve the proposed merger with Chemist Warehouse (CWH), given it has largely been priced in by the market already, an analyst believes. Australia’s competition watchdog is